OUR BLOG
Keys for Entering the US Biotech Market
Overall healthcare industry is very resilient to recessions and even more the strong innovators biotech firms. Also, with Big pharma having more than USD 170 Billion in excess reserves, they are ready for M&A spending in biotech. Already in 2021, venture capital in biotech was 60% higher than in 2020, deals were 66% larger, and […]
Read more